Literature DB >> 31485105

Noninvasive Ventilation-assisted Bronchoscopy in High-risk Hypoxemic Patients.

Mrinal Sircar1, Onkar K Jha1, Gurmeet S Chabbra2, Sandip Bhattacharya3.   

Abstract

BACKGROUND AND AIMS: Hypoxemic patients undergoing fiber-optic bronchoscopy (FOB) are at risk of worsening of respiratory failure requiring mechanical ventilation due to FOB procedure itself and its complications. As patients with respiratory failure are frequently managed by non-invasive ventilation (NIV); feasibility of FOB through NIV mask has been evaluated in some studies to avoid intubation. We describe here our own case series.
MATERIALS AND METHODS: Clinical data of 28 FOB done through NIV mask in 27 intensive care unit (ICU) patients over 6 years period at our center was collected retrospectively and analysed.
RESULTS: Study comprises 27 (17 male; 52±21.6 years age) hypoxemic (PaO2 71.3±14.2, on NIV and oxygen supplementation) patients. All FOB were done at bedside, 15 of them were given sedation for the procedure. Twenty four patients had bronchoalveolar lavage (BAL); three underwent bronchial biopsies, four brush cytology and seven transbronchial biopsies. In 10 patients lung or lobar collapse was reversed. There was no significant change between pre and post bronchoscopy ABG parameters except for improved post FOB PaO2 (p = 0.0032) and SpO2 (p = 0.0046). One patient (3.57%) developed late pneumothorax and 3 patients (10.7%) had bleeding after biopsy. Prior to bronchoscopy 17 (16 BIPAP, 1 CPAP) patients were already on NIV. Two patients required mechanical ventilation 6 hours after FOB due to subsequent clinical deterioration but could be weaned off later. One patient died on third day after FOB from acute myocardial infarction.
CONCLUSION: Hypoxemic patients in ICU can safely undergo bedside diagnostic and simple therapeutic bronchoscopy with NIV support while mostly avoiding intubation and with low complication rates. HOW TO CITE THIS ARTICLE: Sircar M, Jha OK, Chabbra GS, Bhattacharya S. Noninvasive Ventilation-assisted Bronchoscopy in High-risk Hypoxemic Patients. Indian J Crit Care Med 2019;23(8):363-367.

Entities:  

Keywords:  Bronchoscopy; FOB; NIV; Noninvasive ventilation; Respiratory failure

Year:  2019        PMID: 31485105      PMCID: PMC6709836          DOI: 10.5005/jp-journals-10071-23219

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


INTRODUCTION

Patients with respiratory failure in intensive care unit (ICU) may require fiber-optic bronchoscopy (FOB). However, FOB itself can lead to hypoxemia, hypotension, tracheobronchial bleeding or cardiac arrhythmias.[1,2] Although empirical treatment is possible, etiological diagnosis is necessary for targeted treatment.[3] Strategies for microbiological diagnosis may include sputum or endotracheal aspirate examination. In non-intubated patients FOB may be done via laryngeal mask airway[4] or by intubating them.[5] These invasive methods may be avoided by using non-invasive ventilation (NIV) during FOB.[5-18] An alternative technique using high-flow nasal cannula oxygen therapy during FOB is also emerging.[19] Bronchoscopy with NIV support is relatively less used technique with small number of published papers and only one from India.[16] We have been using this technique and our experience over a period of six years is presented here.[20]

MATERIALS AND METHODS

The study population comprised of 27 patients undergoing 28 bedside FOB procedures on NIV during a period of six years in a medical–surgical ICU. Intent of bronchoscopy was therapeutic in 10 patients with atelectasis (four patients with one lung and six with lobar collapse) that were unresponsive to physiotherapy and was diagnostic in the remaining eighteen. Of these 28 patients’ episodes, 17 were already on NIV (16 on BIPAP and one on CPAP). All these patients were observed to desaturate even with a brief discontinuation (<10 minutes) of NIV and were therefore considered unfit for bronchoscopy off NIV. The patient on CPAP was electively switched to BIPAP for FOB. The remaining 11 patients (included four with lung collapse and rest with diffuse lung diseases) had PaO2/FiO2 ratio <300, respiratory rate >30 per min and using accessory muscles of respiration but were not candidates for immediate intubation. These 11 patients were put electively on BIPAP, based on clinical judgement, one hour before FOB. Noninvasive ventilation was delivered through a tight fitting anaesthesia face mask (Intersurgical Ltd., Berkshire, UK), kept in place using adjustable straps. This mask was then attached to a catheter mount with inbuilt bronchoscopy port, an Oxygen enrichment connector with inbuilt expiratory port (Respironics; Murrysville, PA) and a single limb NIV circuit that was attached to BiPAP-S/T30 machine (BiPAP; Respironics; Murrysville, PA) (Fig. 1). Oxygen was bled into the NIV circuit and flow was adjusted to keep SpO2 above 90% during the bronchoscopy procedure.
Fig. 1

Fiber-optic bronchoscopy through non-invasive ventilation. (a) Anesthesia face mask; (b) Fiber-optic bronchoscope; (c) Trap for BAL collection; (d) Catheter mount; (e) Bite guard; (f) Oxygen enrichment connector; (g) Oxygen tubing; (h) Pulse oximeter; (i) Noninvasive BP cuff

Fiber-optic bronchoscopy through non-invasive ventilation. (a) Anesthesia face mask; (b) Fiber-optic bronchoscope; (c) Trap for BAL collection; (d) Catheter mount; (e) Bite guard; (f) Oxygen enrichment connector; (g) Oxygen tubing; (h) Pulse oximeter; (i) Noninvasive BP cuff Sixteen patients were already on BIPAP and they continued on their preexisting setting of IPAP of 12–20 cm H2O and EPAP of 4–8 cm H2O. For the remaining 12 (including patient on CPAP) patients’ initial settings were IPAP of 12 cm H2O and EPAP of four cm H2O and this was adjusted based on clinical response. All patients were also put on a backup rate of 12 breaths per min. Arterial blood gas(ABG) analysis was obtained after one hour when stable clinical parameters were achieved for these 12 patients, as also for all other patients, before proceeding to FOB. ABG was repeated one hour after FOB procedure. All patients received topical anesthesia (10% lignocaine throat spray and 2% lignocaine via bronchoscope). Sedation was used as infusion during 15 bronchoscopies (1% Propofol in 14 patients and Midazolam in one patient).[15] All patients had bedside ECG, (non-invasive or arterial) blood pressure and pulse oximetry monitoring during the procedure. A critical care physician provided the sedation and monitored the patient during and after FOB procedure. All bronchoscopies were done by consultant pulmonologists. Bronchoscopy was done through nasal passage in 23 patients and through oral route in five patients (using a bite guard inside the NIV mask). Fiber-optic bronchoscope used (Olympus BF-1T30) had 6.0-mm outer diameter with 2.8 mm instrument channel. Chest X-ray was done in all patients two hours after FOB procedure.

RESULTS

Twenty-eight FOB procedures (in 27 patients, 18 males, mean +SD age 52+21.6 years) were done using NIV support. Demographic details are shown in (Table 1). Indications and results of bronchoscopy are given in (Table 2).
Table 1

Characteristics of study population

ParametersValue
Age (years) mean ± SD52 ± 21.6
Gender n (%):   Male   Female18 (64.3) 10 (35.7)
Comorbid Illnesses n(%):   Coronary artery disease   Cerebral vascular accident   Hypertension   Chronic renal failure   Bronchial arthma   Diabetes mellitus   Obstructive sleep apnea   Interstitial lung disease1 (3.57) 3 (10.7) 4 (14.3) 1 (3.57) 1 (3.57) 1 (3.57) 1 (3.57) 3 (10.7)
Immunosupression n(%):   Malignancy hematological   Malignancy solid organ   Long-term steroid1 (3.57) 3 (10.7) 4 (14.3)
Reason of respiratory failure n(%):   Pneumonia   ARDS   Atelectasis   Pulmonary hemorrhage   Diffuse infiltrates6 (21.4) 1 (3.57) 14 (50) 2 (7.14) 5 (15.3)
Type of bronchoscopy n(%):   Diagnostic   Therapeutic18 (64.2) 10 (35.7)
Use of NIV n (%):   Preprocedure   Intraprocedure   Postprocedure16 (57.1) 28 (100) 19 (67.9)
Route of bronchoscopy n (%):   Nasal   Oral23 (82.1) 5 (21.7)
Postprocedure complication n(%):   Pneumothorax   Bleeding   Mechanical ventilation1 (3.57) 4 (14.3) 2 (7.14)
Table 2

Indications and results of fiber-optic bronchoscopy

Case #FOB IndicationSedationBronchoscopy resultMicroorganismComplication
1AtelectasisNo sedationInfectionPseudomonas aeruginosaNone
2Nodular infiltratesPropofolInfection, neoplasia (carcinoid)M. Tuberculosis, Candida albicansLate pneumothorax, Mechanical ventilation
3Bilateral infiltratesPropofolInfectionE. coliNone
4Atelectasis, blunt trauma abdomen (post-laparotomy)No sedationAtelectasisStains and culture negativeNone
5AtelectasisNo sedationInfectionProteus mirabilisNone
6AtelectasisPropofolInfectionKlebsiella pneumoniaeNone
7Atelectasis, CRF with uremic pleural effusionPropofolAtelectasisStains and culture negativeNone
8PneumoniaNo sedationInfection, atypical cellGram-negative bacilliBleeding
9AtelectasisNo sedationInfection, mucous pluggingKlebsiella pneumoniaeNone
10AtelectasisNo sedationInfectionGram-negative bacilliNone
11Bilateral infiltratesPropofolInfectionPseudomonas, GPC, pseudohyphaeBleeding
12Infiltrates, pulmonary noduleNo sedationInfection, nonsmall cell carcinomaCandida albicansNone
13AtelectasisNo sedationInfection,Candida albicansNone
14AtelectasisPropofolInfectionE. coli, Klebsiella pneumoniaeNone
15AtelectasisPropofolInfection, mucous pluggingGram-negative bacilliNone
16Pulmonary hemorrhagePropofolChronic inflammationStains and culture negativeMechanical ventilation
17AtelectasisNo sedationInfectionKlebsiella pneumoniaeNone
18AtelectasisPropofolBlood clotStains and culture negativeNone
19Pulmonary hemorrhagePropofolInterstitial lung disease (UIP)Stains and culture negativeNone
20Organizing pneumoniaPropofolInterstitial lung disease (BOOP)Stains and culture negativeNone
21PneumoniaPropofolCopious secretions in tracheobronchial treeStains and culture negativeNone
22ARDS, pneumoniaNo sedationInfectionPseudomonas aeruginosaNone
23AtelectasisNo sedationInfectionE.coliNone
24PneumoniaNo sedationInfectionAcenetobacter baumanniiBleeding
25AtelectasisNo sedationInfectionCandida albicansNone
26StridorMidazolamVocal cord edemaStains and culture negativeNone
27Organizing pneumoniapropofolOrganizing pneumoniaStains and culture negativeNone
28Bilteral infiltratespropofolChronic inflammatory cellsStains and culture negativeNone
Collapsed lung or lobes were successfully opened up in all 10 patients by repeated saline and N-acetyl cysteine instillations and suctioning. Broncheoalveolar lavage (BAL) samples were obtained in 24 patients. Bronchial biopsies were done in three patients, brush cytology in four patients and transbronchial biopsies (TBLB) (without using C-arm) in seven patients. Characteristics of study population All procedures were well tolerated; no patient needed endotracheal intubation and no hemodynamic instability occurred during FOB. Sedation was well tolerated by patients. Three patients had significant bleeding during FOB that was controlled with bronchoscopic instillation of adrenaline and cold saline. Routine postprocedure chest X-rays after two hours did not reveal any pneumothorax. There was significant improvement in oxygenation noted in post bronchoscopy ABGs in comparison with pre-FOB ABG (Table 3).
Table 3

Arterial blood gas parameters pre- and postfiber-optic bronchoscopy

ParametersPreprocedurePostprocedureSignificance
pH7.404 ± 0.06347.404 ± 0.05560.3106
PaCO2 (mm Hg)40.057 ± 8.52840.021 ± 7.1980.6186
PaO2 (mm Hg)71.296 ± 14.16080.079 ± 19.4000.0032
HCO3 (mmol/L)25.396 ± 5.09625.064 ± 4.8430.5599
SpO2 (%)92.071 ± 3.76193.607 ± 3.8810.0046
All patients on pre-FOB NIV (17 patients) remained on BIPAP afterwards too without requiring intubation. Of the remaining 11 patients, NIV could be discontinued 1–2 hours after FOB in eight patients; one of them developed acute respiratory distress six hours after FOB including TBLB. A repeat chest X-ray revealed a delayed pneumothorax requiring emergent intercostal tube drainage and invasive mechanical ventilation. The patient could be successfully extubated after two days. However, a day later he died of myocardial infarction. This patient had history of myocardial infarction five year back. Indications and results of fiber-optic bronchoscopy Arterial blood gas parameters pre- and postfiber-optic bronchoscopy Final bronchoscopic diagnosis for this patient was pulmonary tuberculosis and atypical carcinoid (Table 2, Case 2). Another patient with diffuse lung disease (Table 2, Case 16), who was put on NIV only for FOB but NIV could not be discontinued afterwards, needed elective mechanical ventilation six hours later due to worsening respiratory distress. He too could be extubated later.

DISCUSSION

Fiber-optic bronchoscopy is extensively used in ICUs for diagnosis of pulmonary pathology and mucous plugging. However, bronchoscopy is often associated with temporary changes in gas exchange and lung mechanics.[21-25] Fiber-optic bronchoscope occupies about 10% of tracheal cross section in nonintubated patients and this can increase work of breathing.[26] In contrast, a 5.7 mm bronchoscope occupies 40% of a 9.0 mm internal diameter (ID) endotracheal tube and 66% of a 7.0-mm ID endotracheal tube[27] potentially increasing the work of breathing even more. Significant changes in gas exchange parameters occur during FOB, primarily during suctioning. Hypoxemia during or immediately after taking BAL is most common complication.[28] PaCO2 increases by about 30% and PaO2 is decreased by 40%.[21] Around 200–300 mL of tidal volume is lost during each suctioning period. These changes in blood gases result from decrease in lung volumes and loss of functional gas exchange surface during BAL and reflex bronchospasm due to stimulation of vagal receptors in upper airways. Desaturation during bronchoscopy has also been attributed to upper airway collapse that can be reversed by placement of nasopharengeal airway.[29] The delay before normalization of gas exchange varies from about 15 minutes for normal lungs to several hours in those with parenchymal disease.[26,30] Significant cardiopulmonary risk has been reported in up to 13% ventilated patients during bronchoscopy.[30] The American Thoracic Society recommends avoiding BAL in patients spontaneously breathing with hypercapnia and/or hypoxemia and who cannot be corrected to at least PaO2 of 75 mm Hg or to SpO2 more than 90% with supplemental oxygen.[1] Noninvasive ventilation has been successfully used for respiratory failure – it decreases work of breathing, improves lung mechanics, recruits closed alveoli, improves blood gases and avoids intubation and mechanical ventilation.[7,31] As an extension, it has been used to perform FOB in patients with respiratory failure[14] and it has been to shown to help in improving oxygen saturation and arterial oxygen tension and avoid invasive ventilation. Mechanisms for these are likely to be same as for treatment of respiratory failure with NIV. Further as a corollary with obstructive sleep apnea, NIV is likely to counter upper airway collapse during bronchoscopy.[32,33] Moreover, as the presence of the bronchoscope within the trachea reduces its caliber and increases airway resistance and work of breathing, application of NPPV may compensate for this extra-work load, thereby improving the tolerability and safety of the bronchoscopic procedure. Small number of studies, mostly observational, have shown successful use of NIV assisted FOB in COPD,[6,18] immunocompromized patients with pneumonia,[5] acute respiratory failure with or without pneumonia in ICU,[13,15,16,34] ARDS patients[17,35] and non ICU hypoxemic patients.[12] Few randomized control trials of NIV versus Oxygen supplementation[7,8] and NIV versus mechanical ventilation[13] have all reported benefit of from using NIV during FOB. Even upper gastrointestinal endoscopy,[36] endoscopic retrograde cholangiopancreatography[37] and transesophageal echocardiography[38] have been successfully done under NIV support. In yet another study COPD patient in exacerbations with mild encephalopathy and inability to clear secretions were randomized to only NIV versus NIV combined with early FOB for bronchial toileting and latter had superior clinical outcomes.[18] In our study too all 27 patients could successfully undergo 28 FOB procedure with NIV support without need for immediate intubation. This is one of the largest study evaluating feasibility of FOB in patients on NIV support. All published studies have reported NIV supported FOB guided BAL procedures. Only few studies like Maitre et al. (6 patients) and Chiner et al (eight patients) have reported bronchial biopsies while Agarwal R has reported transbronchial biopsies (six patients) during FOB on NIV support.[7,16,34] Protected brushing has been reported by Chiner et al.[34] In our study too we have reported obtaining BAL (24 patients), bronchial (three patients) and transbronchial (seven patients) biopsies as well as brushings (4 patients) safely.[20] Three patients had significant bleed that was managed successfully while only one patient had (late) pneumothorax. Two of our patients needed intubation and mechanical ventilation within 24 hours of bronchoscopy as have been reported earlier by other authors.[7,8,14,15,17,18] The first one needed ventilation after developing a delayed pneumothorax that could be a possible complication of transbronchial biopsy procedure during preceding FOB or simply due to the underlying disease (pulmonary tuberculosis with atypical carcinoid) itself. The patient could be successfully extubated two days later after complete resolution of pneumothorax and resultant respiratory deterioration. The second patient needing mechanical ventilation after FOB had bilateral lung contusion after a road traffic accident and had only been subjected to BAL. Worsening of gas exchange is well known after BAL,[21,28] which may or may not be prevented or reversed by application of NIV. This patient too could be extubated later. Overall there was improvement in oxygenation although FOB can adversely affect it, perhaps due to inclusion of 10 patients who had resolution of their lung/lobe collapse. All our patients were admitted in ICU. Bronchoscopy was therapeutic for 10 patients as they succeeded in opening up atelectatic areas. In 18 remaining instances FOB was primarily diagnostic in intent. Except for a few studies[11,12] others too have done FOB with NIV support only for ICU patients. We used sedation for 15 of 28 FOB procedures and it was well tolerated as has been reported by others in hypoxemic patients in general[39] and during NIV supported FOB.[15,40] Different interfaces have been used for FOB on NIV support including oro-nasal mask,[5,8,16,17] full face mask,[14,18] nasal mask with bite block covered by glove finger through which FOB is introduced,[10,34] helmet mask,[9] modified total face mask[12] and Boussignac CPAP coupled to a face mask.[7] No study till date has compared different types of masks. We used a dedicated NIV device (BiPAP-ST) for our FOB procedures. Other studies have reported using either ICU ventilators to deliver NIV[5,8,13,14,16,17] or dedicated NIV devices[17,34] or even Boussignac CPAP device.[7] All approaches seem to work equally well though no study has tried to compare different NIV devices. Our study has shown that NIV can facilitate both diagnostic and therapeutic bronchoscopic procedures in selected hypoxemic ICU patients while mostly avoiding intubation. Not only BAL but biopsies and brushing could be done safely. Close monitoring of vital signs is required both before initiation of FOB and for extended periods afterwards as late complications can occur. All bronchoscopies were however performed by experienced pulmonologists while being monitored by intensivists with combined expertise to manage complications of FOB.
  35 in total

1.  [Fiberoptic bronchoscopy during noninvasive positive-pressure ventilation in patients with chronic obstructive lung disease with hypoxemia and hypercapnia].

Authors:  M Da Conceiçao; G Genco; J C Favier; I Bidallier; R Pitti
Journal:  Ann Fr Anesth Reanim       Date:  2000-04

2.  [Description of a new procedure for fiberoptic bronchoscopy during noninvasive ventilation through a nasal mask in patients with acute respiratory failure].

Authors:  E Chiner; M Llombart; J Signes-Costa; A L Andreu; E Gómez-Merino; E Pastor; J M Arriero
Journal:  Arch Bronconeumol       Date:  2005-12       Impact factor: 4.872

3.  Bronchoscopy with bronchoalveolar lavage via the laryngeal mask airway in high-risk hypoxemic immunosuppressed patients.

Authors:  G Hilbert; D Gruson; F Vargas; R Valentino; J C Favier; L Portel; G Gbikpi-Benissan; J P Cardinaud
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

4.  Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. A randomized double-blind study using a new device.

Authors:  B Maitre; S Jaber; S M Maggiore; E Bergot; J C Richard; H Bakthiari; B Housset; G Boussignac; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

5.  Use of continuous positive airway pressure during flexible bronchoscopy in young children.

Authors:  D Trachsel; T O Erb; F J Frei; J Hammer
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

6.  Noninvasive positive-pressure ventilation vs. conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy.

Authors:  Massimo Antonelli; Giorgio Conti; Monica Rocco; Andrea Arcangeli; Franco Cavaliere; Rodolfo Proietti; Gianfranco Umberto Meduri
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

7.  Management of acute hypoxemia during flexible bronchoscopy with insertion of a nasopharyngeal tube in lung transplant recipients.

Authors:  Prashant N Chhajed; Christina Aboyoun; Monique A Malouf; Peter M Hopkins; Marshall Plit; Ronald R Grunstein; Allan R Glanville
Journal:  Chest       Date:  2002-04       Impact factor: 9.410

Review 8.  NIH conference. Respiratory disease in the immunosuppressed patient.

Authors:  J H Shelhamer; G B Toews; H Masur; A F Suffredini; P A Pizzo; T J Walsh; D K Henderson
Journal:  Ann Intern Med       Date:  1992-09-01       Impact factor: 25.391

9.  Fiberoptic bronchoscopy during noninvasive positive pressure ventilation delivered by helmet.

Authors:  Massimo Antonelli; Mariano Alberto Pennisi; Giorgio Conti; Giuseppe Bello; Salvatore Maurizio Maggiore; Vincenzo Michetti; Franco Cavaliere; Rodolfo Proietti
Journal:  Intensive Care Med       Date:  2002-11-29       Impact factor: 17.440

Review 10.  Bronchoscopy in the intensive care unit.

Authors:  P Jolliet; J C Chevrolet
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

View more
  1 in total

1.  ISCCM Guidelines for the Use of Non-invasive Ventilation in Acute Respiratory Failure in Adult ICUs.

Authors:  Rajesh Chawla; Subhal B Dixit; Kapil Gangadhar Zirpe; Dhruva Chaudhry; G C Khilnani; Yatin Mehta; Khalid Ismail Khatib; Bharat G Jagiasi; Gunjan Chanchalani; Rajesh C Mishra; Srinivas Samavedam; Deepak Govil; Sachin Gupta; Shirish Prayag; Suresh Ramasubban; Jayesh Dobariya; Vikas Marwah; Inder Sehgal; Sameer Arvind Jog; Atul Prabhakar Kulkarni
Journal:  Indian J Crit Care Med       Date:  2020-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.